(Q40633551)

22 September 2017

title

Experimental therapy of disseminated B-Cell lymphoma xenografts with 213Bi-labeled anti-CD74 (English)

1 reference

https://api.crossref.org/works/10.1016/S0969-8051(03)00082-9

11 March 2024

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0969-8051(03)00082-9

11 March 2024

author name string

Rosana B. Michel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14499329

11 March 2024

Adriane V. Rosario

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14499329

11 March 2024

Martin W. Brechbiel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14499329

11 March 2024

Thomas J. Jackson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14499329

11 March 2024

David M. Goldenberg

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14499329

11 March 2024

M. Jules Mattes

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14499329

11 March 2024

language of work or name

1 reference

1 October 2003

1 reference

full work available at URL

22 September 2017

https://api.elsevier.com/content/article/PII:S0969805103000829?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0969-8051(03)00082-9

https://api.elsevier.com/content/article/PII:S0969805103000829?httpAccept=text/plain

11 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0969-8051(03)00082-9

Nuclear Medicine and Biology

11 March 2024

published in

1 reference

22 September 2017

volume

30

1 reference

22 September 2017

issue

7

1 reference

22 September 2017

page(s)

715-723

1 reference

Delivery of the alpha-emitting radioisotope bismuth-213 to solid tumors via single-chain Fv and diabody molecules

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900082-9

7 January 2021

Dose-Survival Curves of Human Cells in Tissue Culture Irradiated with Alpha-, Beta-, 20-KV. X- and 200-KV. X-Radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900082-9

7 January 2021

scid mutation in mice confers hypersensitivity to ionizing radiation and a deficiency in DNA double-strand break repair

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900082-9

7 January 2021

Optimizations of Radiolabeling of Immunoproteins with 213Bi

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900082-9

7 January 2021

The SCID mouse mutant: definition, characterization, and potential uses

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900082-9

7 January 2021

Disseminated or localized growth of a human B-cell tumor (Daudi) in SCID mice

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900082-9

7 January 2021

Cytotoxicity with Auger electron-emitting radionuclides delivered by antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900082-9

7 January 2021

Internalization and catabolism of radiolabelled antibodies to the MHC class-II invariant chain by B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900082-9

7 January 2021

Bismuth-212-labeled anti-Tac monoclonal antibody: alpha-particle-emitting radionuclides as modalities for radioimmunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900082-9

7 January 2021

High-efficiency astatination of antibodies using N-iodosuccinimide as the oxidising agent in labelling of N-succinimidyl 3-(trimethylstannyl)benzoate

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900082-9

7 January 2021

Cellular kinetics, dosimetry, and radiobiology of alpha-particle radioimmunotherapy: induction of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900082-9

7 January 2021

Radionuclide-antibody conjugates for single-cell cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900082-9

7 January 2021

An 225Ac/213Bi generator system for therapeutic clinical applications: construction and operation

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900082-9

7 January 2021

Tumor therapy with targeted atomic nanogenerators

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900082-9

7 January 2021

Astatine-211 labeling of internalizing anti-EGFRvIII monoclonal antibody using N-succinimidyl 5-[211At]astato-3-pyridinecarboxylate

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900082-9

7 January 2021

Cell surface HLA-DR-invariant chain complexes are targeted to endosomes by rapid internalization

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900082-9

7 January 2021

A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclide

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900082-9

7 January 2021

Long-lived alpha emitters in radioimmunotherapy: the mischievous progeny

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900082-9

7 January 2021

Stereochemical influence on the stability of radio-metal complexes in vivo. Synthesis and evaluation of the four stereoisomers of 2-(p-nitrobenzyl)-trans-CyDTPA

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900082-9

7 January 2021

Pretargeting radioimmunotherapy of a murine model of adult T-cell leukemia with the alpha-emitting radionuclide, bismuth 213.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2803%2900082-9

7 January 2021

Identifiers

1 reference

22 September 2017

1 reference